Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreren
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ASCENDIS PHARMA A/S

(ASND)
  Rapport
Vertraagde tijd Nasdaq  -  22:00:00 03-02-2023
116.10 USD   -1.39%
18/01Technologieaandelen leiden Europese aandelen licht hoger in de woensdaghandel
MT
17/01Farmaceutische aandelen leiden Europese aandelen hoger in de dinsdaghandel
MT
17/01Ascendis Pharma A/S : SVB Securities LLC herhaalt koopadvies voor het aandeel
MM
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
ETF's gepositioneerd op ASCENDIS PHARMA A/SETF's en trackers met Trackinsight
ETF gewichtVariatie 5 dagenRatingGeografie
ALPS Medical Breakthroughs ETF - USD2.97%0.75%VS
Virtus LifeSci Biotech Products ETF - USD1.91%0.03%VS
Global X Guru Index ETF - USD1.61%1.02%VS
Mackenzie Maximum Diversification Developed...1.05%0.66%Europa
Mackenzie Maximum Diversification All World...0.65%-0.41%Wereld
Invesco Nasdaq Biotechnology ETF - USD0.6%-0.46%-VS
IShares Nasdaq US Biotechnology (D) - USD0.59%-0.02%VS
IShares Nasdaq US Biotechnology - USD0.59%-0.10%VS
IShares Biotechnology ETF - USD0.45%-0.47%-NC
Mackenzie Maximum Diversification All World...0.12%0.26%-Wereld
Fidelity NASDAQ Composite Index ETF - USD0.03%3.47%-VS



Copyright © 2009 Morningstar. All Rights Reserved. The information, data and opinions expressed (ďInformationĒ) and contained herein: (1) are proprietary to Morningstar and/or its content providers and are not intended to represent investment advice or recommendation to buy or sell any security; (2) may not be copied or distributed without express license to do so; and (3) are not warranted to be accurate, complete or timely. Morningstar reserve its rights to charge for access to these Ratings and/or Rating report. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this Rating, Rating Report or Information contained therein.
Grafiek ASCENDIS PHARMA A/S
Duur : Periode :
Ascendis Pharma A/S : Grafische technische analyse Ascendis Pharma A/S | MarketScreener
Grafiek op volledig scherm
Evolutie van de resultatenrekening
Consensus
Verkoop
Koop
Gemiddeld advies Kopen
Aantal analisten 14
Laatste slotkoers 106,99 €
Gemiddelde koersdoel 146,94 €
Spread / Gemiddelde doel 37,3%
Grafiek ASCENDIS PHARMA A/S
Duur : Periode :
Ascendis Pharma A/S : Grafische technische analyse Ascendis Pharma A/S | MarketScreener
Grafiek op volledig scherm
Sector en concurrentie
Verschil t.o.v. 1 jan (%)Kapitalisatie (M$)
ASCENDIS PHARMA A/S-4.94%6 501
REGENERON PHARMACEUTICALS, INC.4.12%83 640
VERTEX PHARMACEUTICALS5.19%77 269
WUXI APPTEC CO., LTD.15.80%40 679
BIONTECH SE-5.43%34 523
BEIGENE, LTD.16.80%26 752